Two Seas Capital's Stance on Core Scientific's Deal
Two Seas Capital LP, an alternative investment management firm, has voiced significant concerns regarding Core Scientific, Inc.'s proposed sale to CoreWeave, Inc. Two Seas, which is recognized as the largest active shareholder of Core Scientific, released a detailed investor presentation outlining their objections to the transaction.
The Investor Presentation Insights
The presentation details the reasons why Two Seas believes the proposed sale is not only flawed but also detrimental to shareholder value. Notably, Two Seas asserts that the process leading to this sale lacks transparency and robustness, fearing it undervalues Core Scientific's worth.
Opposition to the Transaction
Two Seas urges all shareholders of Core Scientific to actively participate by voting against the proposed transaction. The firm is advocating for a thorough reevaluation of the deal's terms, claiming they fall short of what Core Scientific's assets are truly worth.
Core Scientific's Market Position
The push against the acquisition comes at a time when Core Scientific is seen as a key player in the booming sector of high-performance computing. The demand for AI-driven infrastructure continues to surge, and Two Seas believes that Core Scientific is uniquely situated to capitalize on this growth.
Impacts of Market Trends
Despite the unique position of Core Scientific in the market, the investor presentation points out a decline in its stock price since the announcement of the acquisition, contrasting it with the rising value of its competitors. This disparity raises alarms about the adequacy of the proposed sale's terms.
Statements from the Leadership
Sina Toussi, the Founder and Chief Investment Officer of Two Seas Capital, highlighted that the current offer is not reflective of Core Scientific's valuable assets. He encouraged other shareholders to review the analysis presented thoroughly, indicating that a decision to support the deal could negatively impact shareholders' financial interests.
Moving Forward
As the special meeting approaches, Two Seas remains committed to mobilizing shareholders to reject the proposed sale. They believe that a standalone future is much brighter for Core Scientific, asserting that other alternatives present better opportunities for maximizing shareholder value.
About Two Seas Capital
Founded in 2020, Two Seas Capital specializes in event-driven investments with a value-centric approach. With approximately $1.9 billion in assets under management, the firm emphasizes thorough analysis and strategic investments tailored to market conditions. The spirit of investing at Two Seas is grounded in identifying untapped market potentials, making them a powerful advocate in corporate matters like this acquisition.
Investor Relations Contact
For inquiries related to investor relations, Scott Winter and Jonathan Salzberger from Innisfree M&A Incorporated can be reached. Interested parties may contact via email at info@innisfreema.com or call at (212) 750-5833.
Frequently Asked Questions
What is the central concern Two Seas Capital has regarding the acquisition?
Two Seas Capital believes the sale undervalues Core Scientific and is calling for a vote against the transaction.
What is the significance of the proposed deal?
The deal is seen as critical because Core Scientific holds strategic assets in high-performance computing amid rising demand.
How does the proposed sale affect shareholders?
Shareholders may face losses if the sale proceeds at inadequate valuations compared to Core Scientific's market potential.
Who are the key figures related to this issue?
Sina Toussi, as the Chief Investment Officer, has been vocal against the sale, urging shareholders to consider the implications.
How can shareholders get involved?
Shareholders are encouraged to vote against the transaction using the GOLD proxy card and to review Two Seas' investor presentation.
